|
1
|
Pittenger MF, Mackay AM, Beck SC, Jaiswal
RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and
Marshak DR: Multilineage potential of adult human mesenchymal stem
cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rao MS and Mattson MP: Stem cells and
aging: expanding the possibilities. Mech Ageing Dev. 122:713–734.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fernández M, Simon V, Herrera G, Cao C,
Del Favero H and Minguell JJ: Detection of stromal cells in
peripheral blood progenitor cell collections from breast cancer
patients. Bone Marrow Transplant. 20:265–271. 1997.PubMed/NCBI
|
|
4
|
Erices A, Conget P and Minguell JJ:
Mesenchymal progenitor cells in human umbilical cord blood. Br J
Haematol. 109:235–242. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL
and Chen TH: Isolation of multi-potent mesenchymal stem cells from
umbilical cord blood. Blood. 103:1669–1675. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Miura M, Gronthos S, Zhao M, Lu B, Fisher
LW, Robey PG and Shi S: SHED: stem cells from human exfoliated
deciduous teeth. Proc Natl Acad Sci USA. 100:5807–5812. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Romanov YA, Svintsitskaya VA and Smirnov
VN: Searching for alternative sources of postnatal human
mesenchymal stem cells: candidate MSC-like cells from umbilical
cord. Stem Cells. 21:105–110. 2003.PubMed/NCBI
|
|
8
|
Yen BL, Huang HI, Chien CC, Jui HY, Ko BS,
Yao M, Shun CT, Yen ML, Lee MC and Chen YC: Isolation of
multipotent cells from human term placenta. Stem Cells. 23:3–9.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Goodwin HS, Bicknese AR, Chien SN, Bogucki
BD, Quinn CO and Wall DA: Multilineage differentiation activity by
cells isolated from umbilical cord blood: expression of bone, fat,
and neural markers. Biol Blood Marrow Transplant. 7:581–588. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Parolini O, Alviano F, Bagnara GP, et al:
Concise review: isolation and characterization of cells from human
term placenta: outcome of the first international Workshop on
Placenta Derived Stem Cells. Stem Cells. 26:300–311. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fukuchi Y, Nakajima H, Sugiyama D, Hirose
I, Kitamura T and Tsuji K: Human placenta-derived cells have
mesenchymal stem/progenitor cell potential. Stem cells. 22:649–658.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gilliland DG and Griffin JD: The roles of
FLT3 in hematopoiesis and leukemia. Blood. 100:1532–1542. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rosnet O and Birnbaum D: Hematopoietic
receptors of class III receptor-type tyrosine kinases. Crit Rev
Oncog. 4:595–613. 1993.PubMed/NCBI
|
|
14
|
Agnès F, Shamoon B, Dina C, Rosnet O,
Birnbaum D and Galibert F: Genomic structure of the downstream part
of the human FLT3 gene:exon/intron structure conservation among
genes encoding receptor tyrosine kinases (RTK) of subclass III.
Gene. 145:283–288. 1994.PubMed/NCBI
|
|
15
|
deLapeyrière O, Naquet P, Planche J,
Marchetto S, Rottapel R, Gambarelli D, Rosnet O and Birnbaum D:
Expression of Flt3 tyrosine kinase receptor gene in mouse
hematopoietic and nervous tissues. Differentiation. 58:351–359.
1995.PubMed/NCBI
|
|
16
|
Maroc N, Rottapel R, Rosnet O, Marchetto
S, Lavezzi C, Mannoni P, Birnbaum D and Dubreuil P: Biochemical
characterization and analysis of the transform ing potential of the
FLT3/FLK2 receptor tyrosine kinase. Oncogene. 8:909–918.
1993.PubMed/NCBI
|
|
17
|
Rottapel R, Turck CW, Casteran N, Liu X,
Birnbaum D, Pawson T and Dubreuil P: Substrate specificities and
identification of a putative binding site for PI3K in the carboxy
tail of the murine Flt3 receptor tyrosine kinase. Oncogene.
9:1755–1765. 1994.PubMed/NCBI
|
|
18
|
Li F, Miao ZN, Xu YY, Zheng SY, Qin MD, Gu
YZ and Zhang XG: Transplantation of human amniotic mesenchymal stem
cells in the treatment of focal cerebral ischemia. Mol Med Report.
6:625–630. 2012.PubMed/NCBI
|
|
19
|
Gatti S, Bruno S, Deregibus MC, Sordi A,
Cantaluppi V, Tetta C and Camussi G: Microvesicles derived from
human adult mesenchymal stem cells protect against
ischemia-reperfusion-induced acute and chronic kidney injury.
Nephrol Dial Transplant. 26:1474–1483. 2011. View Article : Google Scholar
|
|
20
|
Lai RC, Arslan F, Lee MM, et al: Exosome
secreted by MSC reduces myocardial ischemia/reperfusion injury.
Stem Cell Res. 4:214–222. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bruno S, Grange C, Deregibus MC, et al:
Mesenchymal stem cell-derived microvesicles protect against acute
tubular injury. J Am Soc Nephrol. 20:1053–1067. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schweitzer KS, Johnstone BH, Garrison J,
et al: Adipose stem cell treatment in mice attenuates lung and
systemic injury induced by cigarette smoking. Am J Respir Crit Care
Med. 183:215–225. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Herrera MB, Fonsato V, Gatti S, Deregibus
MC, Sordi A, Cantarella D, Calogero R, Bussolati B, Tetta C and
Camussi G: Human liver stem cell-derived microvesicles accelerate
hepatic regeneration in hepatectomized rats. J Cell Mol Med.
14:1605–1618. 2010. View Article : Google Scholar : PubMed/NCBI
|
